Kidney transplantation with concomitant simple nephrectomy by thoracoabdominal approach for patients with huge autosomal dominant polycystic kidney disease (ADPKD): A case report

por Yamada, Yasutoshi, Enokida, Hideki, Mitsuke, Akihiko, Nishimura, Hiroaki, Tatarano, Shuichi, Nakagawa, Masayuki
Publicado 2019

Significance of preoperative screening of deep vein thrombosis and its indications for patients undergoing urological surgery

por Tatarano, Shuichi, Enokida, Hideki, Yonemori, Masaya, Eura, Rumiko, Yoshino, Hirofumi, Nishimura, Hiroaki, Yamada, Yasutoshi, Nakagawa, Masayuki
Publicado 2021

Laparoscopic Surgery for Pheochromocytoma in Hemodialysis Patients

por Tatarano, Shuichi, Mitsuke, Akihiko, Sakaguchi, Takashi, Matsushita, Ryosuke, Inoguchi, Satoru, Yoshino, Hirofumi, Nishimura, Hiroaki, Yamada, Yasutoshi, Enokida, Hideki
Publicado 2022

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

por Sakaguchi, Takashi, Yoshino, Hirofumi, Yonemori, Masaya, Miyamoto, Kazutaka, Sugita, Satoshi, Matsushita, Ryosuke, Itesako, Toshihiko, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2017

Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer

por Sakaguchi, Takashi, Yoshino, Hirofumi, Yonemori, Masaya, Miyamoto, Kazutaka, Sugita, Satoshi, Matsushita, Ryosuke, Itesako, Toshihiko, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2018

Oncogenic effects of RAB27B through exosome independent function in renal cell carcinoma including sunitinib-resistant

por Tsuruda, Masafumi, Yoshino, Hirofumi, Okamura, Shunsuke, Kuroshima, Kazuki, Osako, Yoichi, Sakaguchi, Takashi, Sugita, Satoshi, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2020

Potential new therapy of Rapalink‐1, a new generation mammalian target of rapamycin inhibitor, against sunitinib‐resistant renal cell carcinoma

por Kuroshima, Kazuki, Yoshino, Hirofumi, Okamura, Shunsuke, Tsuruda, Masafumi, Osako, Yoichi, Sakaguchi, Takashi, Sugita, Satoshi, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2020

Targeting NPL4 via drug repositioning using disulfiram for the treatment of clear cell renal cell carcinoma

por Yoshino, Hirofumi, Yamada, Yasutoshi, Enokida, Hideki, Osako, Yoichi, Tsuruda, Masafumi, Kuroshima, Kazuki, Sakaguchi, Takashi, Sugita, Satoshi, Tatarano, Shuichi, Nakagawa, Masayuki
Publicado 2020

Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation

por Yoshino, Hirofumi, Enokida, Hideki, Osako, Yoichi, Nohata, Nijiro, Yonemori, Masaya, Sugita, Satoshi, Kuroshima, Kazuki, Tsuruda, Masafumi, Tatarano, Shuichi, Nakagawa, Masayuki
Publicado 2020

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer

por Okamura, Shunsuke, Yoshino, Hirofumi, Kuroshima, Kazuki, Tsuruda, Masafumi, Osako, Yoichi, Sakaguchi, Takashi, Yonemori, Masaya, Yamada, Yasutoshi, Tatarano, Shuichi, Nakagawa, Masayuki, Enokida, Hideki
Publicado 2021

Novel oncogenic function of mesoderm development candidate 1 and its regulation by MiR-574-3p in bladder cancer cell lines

por TATARANO, SHUICHI, CHIYOMARU, TAKESHI, KAWAKAMI, KAZUMORI, ENOKIDA, HIDEKI, YOSHINO, HIROFUMI, HIDAKA, HIDEO, NOHATA, NIJIRO, YAMASAKI, TAKESHI, GOTANDA, TAKENARI, TACHIWADA, TOKUSHI, SEKI, NAOHIKO, NAKAGAWA, MASAYUKI
Publicado 2011

Dual regulation of receptor tyrosine kinase genes EGFR and c-Met by the tumor-suppressive microRNA-23b/27b cluster in bladder cancer

por CHIYOMARU, TAKESHI, SEKI, NAOHIKO, INOGUCHI, SATORU, ISHIHARA, TOMOAKI, MATAKI, HIROKO, MATSUSHITA, RYOSUKE, GOTO, YUSUKE, NISHIKAWA, RIKA, TATARANO, SHUICHI, ITESAKO, TOSHIHIKO, NAKAGAWA, MASAYUKI, ENOKIDA, HIDEKI
Publicado 2014

microRNA‐99a‐5p induces cellular senescence in gemcitabine‐resistant bladder cancer by targeting SMARCD1

por Tamai, Motoki, Tatarano, Shuichi, Okamura, Shunsuke, Fukumoto, Wataru, Kawakami, Issei, Osako, Yoichi, Sakaguchi, Takashi, Sugita, Satoshi, Yonemori, Masaya, Yamada, Yasutoshi, Nakagawa, Masayuki, Enokida, Hideki, Yoshino, Hirofumi
Publicado 2022

Characterization and treatment of gemcitabine‐ and cisplatin‐resistant bladder cancer cells with a pan‐RAS inhibitor

por Yoshino, Hirofumi, Yokoyama, Seiya, Tamai, Motoki, Okamura, Shunsuke, Iizasa, Sayaka, Sakaguchi, Takashi, Osako, Yoichi, Inoguchi, Satoru, Matsushita, Ryosuke, Yamada, Yasutoshi, Nakagawa, Masayuki, Tatarano, Shuichi, Tanimoto, Akihide, Enokida, Hideki
Publicado 2023

Potential therapeutic target secretogranin II might cooperate with hypoxia‐inducible factor 1α in sunitinib‐resistant renal cell carcinoma

por Fukumoto, Wataru, Yoshino, Hirofumi, Horike, Shin‐Ichi, Kawakami, Issei, Tamai, Motoki, Arima, Junya, Kawahara, Ichiro, Mitsuke, Akihiko, Sakaguchi, Takashi, Inoguchi, Satoru, Meguro‐Horike, Makiko, Tatarano, Shuichi, Enokida, Hideki
Publicado 2023

Low dose tacrolimus exposure and early steroid withdrawal with strict body weight control can improve post kidney transplant glucose tolerance in Japanese patients

por Mitsuke, Akihiko, Ohbo, Takahiko, Arima, Junya, Osako, Yoichi, Sakaguchi, Takashi, Matsushita, Ryosuke, Yoshino, Hirofumi, Tatarano, Shuichi, Yamada, Yasutoshi, Sasaki, Hajime, Tanabe, Tatsu, Fukuzawa, Nobuyuki, Tanaka, Hiroshi, Nishio, Yoshihiko, Hideki, Enokida, Harada, Hiroshi
Publicado 2023

Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort

por Ito, Katsuhiro, Kobayashi, Takashi, Kojima, Takahiro, Hikami, Kensuke, Yamada, Takeshi, Ogawa, Kosuke, Nakamura, Kenji, Sassa, Naoto, Yokomizo, Akira, Abe, Takashige, Tsuchihashi, Kazunari, Tatarano, Shuichi, Inokuchi, Junichi, Tomida, Ryotaro, Fujiwara, Maki, Takahashi, Atsushi, Matsumoto, Kazumasa, Shimizu, Kosuke, Araki, Hiromasa, Kurahashi, Ryoma, Osaki, Yu, Tashiro, Yu, Uegaki, Masayuki, Ogawa, Osamu, Kitamura, Hiroshi, Nishiyama, Hiroyuki
Publicado 2021